Research progress in the relationship between type 2 diabetes mellitus and intestinal flora
The disorder of intestinal flora leads to the decline of anti-inflammatory reaction ability in the intestinal tract, low levels of SCFAs reduced the activation of GPR41 and GPR43, cause the occurrence of intestinal inflammation, insulin resistance, and as a result, lead to the occurrence of T2DM. [D...
Gespeichert in:
Veröffentlicht in: | Biomedicine & pharmacotherapy 2019-09, Vol.117, p.109138-109138, Article 109138 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 109138 |
---|---|
container_issue | |
container_start_page | 109138 |
container_title | Biomedicine & pharmacotherapy |
container_volume | 117 |
creator | Ma, Quantao Li, Yaqi Li, Pengfei Wang, Min Wang, Jingkang Tang, Ziyan Wang, Ting Luo, Linglong Wang, Chunguo Wang, Ting Zhao, Baosheng |
description | The disorder of intestinal flora leads to the decline of anti-inflammatory reaction ability in the intestinal tract, low levels of SCFAs reduced the activation of GPR41 and GPR43, cause the occurrence of intestinal inflammation, insulin resistance, and as a result, lead to the occurrence of T2DM.
[Display omitted]
•Intestinal flora disorders, such as the reduction of beneficial bacteria and the increase of harmful bacteria, are prone to occur in patients with type 2 diabetes mellitus.•The mechanisms of type 2 diabetes induced by intestinal flora imbalance include short-chain fatty acid theory, fatty acid theory, and endotoxin theory, etc.•Treatments based on the regulation of intestinal flora, such as fecal bacteria transplantation, regulating probiotics and content of intestinal SCFAs, may have a role in the prevention and treatment of type 2 diabetes.
Type 2 diabetes mellitus (T2DM) is a common clinical chronic disease, while its pathogenesis is still inconclusive. Intestinal flora, the largest micro-ecological system in the human body, is involved in, meanwhile has a major impact on the body's material and energy metabolism. Recent studies have shown that in addition to obesity, genetics, and islet dysfunction, the disturbance of intestinal flora may partly give rise to diabetes. In this paper, we summarized the current research on the correlation between T2DM and intestinal flora, and concluded the pathological mechanisms of intestinal flora involved in T2DM. Moreover, the ideas and methods of prevention and treatment of T2DM based on intestinal flora were proposed, providing theoretical basis and literature reference for the treatment of T2DM and its complications based on the regulation of intestinal flora. |
doi_str_mv | 10.1016/j.biopha.2019.109138 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2250622214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332219321389</els_id><sourcerecordid>2250622214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-a65399ad4493f812231f8cc24c9aad1ec810618bdfa84109f85ac8269c875cc73</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMozjj6D0SydNMxr6bpRhDxBQOC6MpFSNNbm6Evk44y_94MHV26Cpycc-89H0LnlCwpofJqvSxcP9RmyQjNo5RTrg7QnOYpSSQh2SGakyzlCeeMzdBJCGtCSCq5OkYzTpnIhFRz9P4CAYy3NR58_-EhBOw6PNaAPTRmdH0XajfgAsZvgPixHQAzXDoTFQi4haZx4yZg05UxGKXRdabBVdN7c4qOKtMEONu_C_R2f_d6-5isnh-ebm9WiRVEjYmRKc9zUwqR80pRxjitlLVM2NyYkoJVlEiqirIySsSelUqNVUzmVmWptRlfoMtpbqzwuYkn6NYFGy8zHfSboBlLiWSMURGtYrJa34fgodKDd63xW02J3mHVaz1h1TusesIaYxf7DZuihfIv9MsxGq4nA8SeXw68DtZBZ6F0Huyoy979v-EHQ0yLFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2250622214</pqid></control><display><type>article</type><title>Research progress in the relationship between type 2 diabetes mellitus and intestinal flora</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ma, Quantao ; Li, Yaqi ; Li, Pengfei ; Wang, Min ; Wang, Jingkang ; Tang, Ziyan ; Wang, Ting ; Luo, Linglong ; Wang, Chunguo ; Wang, Ting ; Zhao, Baosheng</creator><creatorcontrib>Ma, Quantao ; Li, Yaqi ; Li, Pengfei ; Wang, Min ; Wang, Jingkang ; Tang, Ziyan ; Wang, Ting ; Luo, Linglong ; Wang, Chunguo ; Wang, Ting ; Zhao, Baosheng</creatorcontrib><description>The disorder of intestinal flora leads to the decline of anti-inflammatory reaction ability in the intestinal tract, low levels of SCFAs reduced the activation of GPR41 and GPR43, cause the occurrence of intestinal inflammation, insulin resistance, and as a result, lead to the occurrence of T2DM.
[Display omitted]
•Intestinal flora disorders, such as the reduction of beneficial bacteria and the increase of harmful bacteria, are prone to occur in patients with type 2 diabetes mellitus.•The mechanisms of type 2 diabetes induced by intestinal flora imbalance include short-chain fatty acid theory, fatty acid theory, and endotoxin theory, etc.•Treatments based on the regulation of intestinal flora, such as fecal bacteria transplantation, regulating probiotics and content of intestinal SCFAs, may have a role in the prevention and treatment of type 2 diabetes.
Type 2 diabetes mellitus (T2DM) is a common clinical chronic disease, while its pathogenesis is still inconclusive. Intestinal flora, the largest micro-ecological system in the human body, is involved in, meanwhile has a major impact on the body's material and energy metabolism. Recent studies have shown that in addition to obesity, genetics, and islet dysfunction, the disturbance of intestinal flora may partly give rise to diabetes. In this paper, we summarized the current research on the correlation between T2DM and intestinal flora, and concluded the pathological mechanisms of intestinal flora involved in T2DM. Moreover, the ideas and methods of prevention and treatment of T2DM based on intestinal flora were proposed, providing theoretical basis and literature reference for the treatment of T2DM and its complications based on the regulation of intestinal flora.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2019.109138</identifier><identifier>PMID: 31247468</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Biomedical Research ; Diabetes Mellitus, Type 2 - microbiology ; Diabetes Mellitus, Type 2 - prevention & control ; Diabetes Mellitus, Type 2 - therapy ; Fatty Acids - metabolism ; Fecal Microbiota Transplantation ; Gastrointestinal Microbiome ; Humans ; Intestinal flora ; Models, Biological ; Research progress ; Type 2 diabetes mellitus</subject><ispartof>Biomedicine & pharmacotherapy, 2019-09, Vol.117, p.109138-109138, Article 109138</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-a65399ad4493f812231f8cc24c9aad1ec810618bdfa84109f85ac8269c875cc73</citedby><cites>FETCH-LOGICAL-c408t-a65399ad4493f812231f8cc24c9aad1ec810618bdfa84109f85ac8269c875cc73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biopha.2019.109138$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31247468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Quantao</creatorcontrib><creatorcontrib>Li, Yaqi</creatorcontrib><creatorcontrib>Li, Pengfei</creatorcontrib><creatorcontrib>Wang, Min</creatorcontrib><creatorcontrib>Wang, Jingkang</creatorcontrib><creatorcontrib>Tang, Ziyan</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Luo, Linglong</creatorcontrib><creatorcontrib>Wang, Chunguo</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Zhao, Baosheng</creatorcontrib><title>Research progress in the relationship between type 2 diabetes mellitus and intestinal flora</title><title>Biomedicine & pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>The disorder of intestinal flora leads to the decline of anti-inflammatory reaction ability in the intestinal tract, low levels of SCFAs reduced the activation of GPR41 and GPR43, cause the occurrence of intestinal inflammation, insulin resistance, and as a result, lead to the occurrence of T2DM.
[Display omitted]
•Intestinal flora disorders, such as the reduction of beneficial bacteria and the increase of harmful bacteria, are prone to occur in patients with type 2 diabetes mellitus.•The mechanisms of type 2 diabetes induced by intestinal flora imbalance include short-chain fatty acid theory, fatty acid theory, and endotoxin theory, etc.•Treatments based on the regulation of intestinal flora, such as fecal bacteria transplantation, regulating probiotics and content of intestinal SCFAs, may have a role in the prevention and treatment of type 2 diabetes.
Type 2 diabetes mellitus (T2DM) is a common clinical chronic disease, while its pathogenesis is still inconclusive. Intestinal flora, the largest micro-ecological system in the human body, is involved in, meanwhile has a major impact on the body's material and energy metabolism. Recent studies have shown that in addition to obesity, genetics, and islet dysfunction, the disturbance of intestinal flora may partly give rise to diabetes. In this paper, we summarized the current research on the correlation between T2DM and intestinal flora, and concluded the pathological mechanisms of intestinal flora involved in T2DM. Moreover, the ideas and methods of prevention and treatment of T2DM based on intestinal flora were proposed, providing theoretical basis and literature reference for the treatment of T2DM and its complications based on the regulation of intestinal flora.</description><subject>Biomedical Research</subject><subject>Diabetes Mellitus, Type 2 - microbiology</subject><subject>Diabetes Mellitus, Type 2 - prevention & control</subject><subject>Diabetes Mellitus, Type 2 - therapy</subject><subject>Fatty Acids - metabolism</subject><subject>Fecal Microbiota Transplantation</subject><subject>Gastrointestinal Microbiome</subject><subject>Humans</subject><subject>Intestinal flora</subject><subject>Models, Biological</subject><subject>Research progress</subject><subject>Type 2 diabetes mellitus</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLxDAUhYMozjj6D0SydNMxr6bpRhDxBQOC6MpFSNNbm6Evk44y_94MHV26Cpycc-89H0LnlCwpofJqvSxcP9RmyQjNo5RTrg7QnOYpSSQh2SGakyzlCeeMzdBJCGtCSCq5OkYzTpnIhFRz9P4CAYy3NR58_-EhBOw6PNaAPTRmdH0XajfgAsZvgPixHQAzXDoTFQi4haZx4yZg05UxGKXRdabBVdN7c4qOKtMEONu_C_R2f_d6-5isnh-ebm9WiRVEjYmRKc9zUwqR80pRxjitlLVM2NyYkoJVlEiqirIySsSelUqNVUzmVmWptRlfoMtpbqzwuYkn6NYFGy8zHfSboBlLiWSMURGtYrJa34fgodKDd63xW02J3mHVaz1h1TusesIaYxf7DZuihfIv9MsxGq4nA8SeXw68DtZBZ6F0Huyoy979v-EHQ0yLFg</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Ma, Quantao</creator><creator>Li, Yaqi</creator><creator>Li, Pengfei</creator><creator>Wang, Min</creator><creator>Wang, Jingkang</creator><creator>Tang, Ziyan</creator><creator>Wang, Ting</creator><creator>Luo, Linglong</creator><creator>Wang, Chunguo</creator><creator>Wang, Ting</creator><creator>Zhao, Baosheng</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201909</creationdate><title>Research progress in the relationship between type 2 diabetes mellitus and intestinal flora</title><author>Ma, Quantao ; Li, Yaqi ; Li, Pengfei ; Wang, Min ; Wang, Jingkang ; Tang, Ziyan ; Wang, Ting ; Luo, Linglong ; Wang, Chunguo ; Wang, Ting ; Zhao, Baosheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-a65399ad4493f812231f8cc24c9aad1ec810618bdfa84109f85ac8269c875cc73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomedical Research</topic><topic>Diabetes Mellitus, Type 2 - microbiology</topic><topic>Diabetes Mellitus, Type 2 - prevention & control</topic><topic>Diabetes Mellitus, Type 2 - therapy</topic><topic>Fatty Acids - metabolism</topic><topic>Fecal Microbiota Transplantation</topic><topic>Gastrointestinal Microbiome</topic><topic>Humans</topic><topic>Intestinal flora</topic><topic>Models, Biological</topic><topic>Research progress</topic><topic>Type 2 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Quantao</creatorcontrib><creatorcontrib>Li, Yaqi</creatorcontrib><creatorcontrib>Li, Pengfei</creatorcontrib><creatorcontrib>Wang, Min</creatorcontrib><creatorcontrib>Wang, Jingkang</creatorcontrib><creatorcontrib>Tang, Ziyan</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Luo, Linglong</creatorcontrib><creatorcontrib>Wang, Chunguo</creatorcontrib><creatorcontrib>Wang, Ting</creatorcontrib><creatorcontrib>Zhao, Baosheng</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine & pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Quantao</au><au>Li, Yaqi</au><au>Li, Pengfei</au><au>Wang, Min</au><au>Wang, Jingkang</au><au>Tang, Ziyan</au><au>Wang, Ting</au><au>Luo, Linglong</au><au>Wang, Chunguo</au><au>Wang, Ting</au><au>Zhao, Baosheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Research progress in the relationship between type 2 diabetes mellitus and intestinal flora</atitle><jtitle>Biomedicine & pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2019-09</date><risdate>2019</risdate><volume>117</volume><spage>109138</spage><epage>109138</epage><pages>109138-109138</pages><artnum>109138</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>The disorder of intestinal flora leads to the decline of anti-inflammatory reaction ability in the intestinal tract, low levels of SCFAs reduced the activation of GPR41 and GPR43, cause the occurrence of intestinal inflammation, insulin resistance, and as a result, lead to the occurrence of T2DM.
[Display omitted]
•Intestinal flora disorders, such as the reduction of beneficial bacteria and the increase of harmful bacteria, are prone to occur in patients with type 2 diabetes mellitus.•The mechanisms of type 2 diabetes induced by intestinal flora imbalance include short-chain fatty acid theory, fatty acid theory, and endotoxin theory, etc.•Treatments based on the regulation of intestinal flora, such as fecal bacteria transplantation, regulating probiotics and content of intestinal SCFAs, may have a role in the prevention and treatment of type 2 diabetes.
Type 2 diabetes mellitus (T2DM) is a common clinical chronic disease, while its pathogenesis is still inconclusive. Intestinal flora, the largest micro-ecological system in the human body, is involved in, meanwhile has a major impact on the body's material and energy metabolism. Recent studies have shown that in addition to obesity, genetics, and islet dysfunction, the disturbance of intestinal flora may partly give rise to diabetes. In this paper, we summarized the current research on the correlation between T2DM and intestinal flora, and concluded the pathological mechanisms of intestinal flora involved in T2DM. Moreover, the ideas and methods of prevention and treatment of T2DM based on intestinal flora were proposed, providing theoretical basis and literature reference for the treatment of T2DM and its complications based on the regulation of intestinal flora.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>31247468</pmid><doi>10.1016/j.biopha.2019.109138</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0753-3322 |
ispartof | Biomedicine & pharmacotherapy, 2019-09, Vol.117, p.109138-109138, Article 109138 |
issn | 0753-3322 1950-6007 |
language | eng |
recordid | cdi_proquest_miscellaneous_2250622214 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Biomedical Research Diabetes Mellitus, Type 2 - microbiology Diabetes Mellitus, Type 2 - prevention & control Diabetes Mellitus, Type 2 - therapy Fatty Acids - metabolism Fecal Microbiota Transplantation Gastrointestinal Microbiome Humans Intestinal flora Models, Biological Research progress Type 2 diabetes mellitus |
title | Research progress in the relationship between type 2 diabetes mellitus and intestinal flora |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T09%3A36%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Research%20progress%20in%20the%20relationship%20between%20type%202%20diabetes%20mellitus%20and%20intestinal%20flora&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Ma,%20Quantao&rft.date=2019-09&rft.volume=117&rft.spage=109138&rft.epage=109138&rft.pages=109138-109138&rft.artnum=109138&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2019.109138&rft_dat=%3Cproquest_cross%3E2250622214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2250622214&rft_id=info:pmid/31247468&rft_els_id=S0753332219321389&rfr_iscdi=true |